ABSTRACT
As we continue to work toward a more equitable future of medicine, it is necessary to recognize the needs distinct to pediatric dermatology to decrease health disparities that affect this patient population. Currently, there is very little research investigating the predominate risk factors and management of pityriasis alba in children with skin of color. Herein, we discuss existing literature on pityriasis alba in children with skin of color, as well as the research and educational needs in this area. J Drugs Dermatol. 2023;22(4) doi:10.36849/JDD.7221 Citation: Hyun Choi S, Beer J, Bourgeois J, et al. Pityriasis alba in pediatric patients with skin of color. J Drugs Dermatol. 2023;22(4):417-418. doi:10.36849/JDD.7221.
Subject(s)
Pityriasis , Humans , Child , Pityriasis/diagnosis , Skin Pigmentation , Skin , Risk FactorsSubject(s)
Humans , Female , Child , Pityriasis/diagnosis , Hair Diseases/diagnosis , Keratoderma, Palmoplantar/diagnosis , Tinea Capitis/diagnosis , SyndromeSubject(s)
Humans , Female , Child , Pityriasis/diagnosis , Hair Diseases/diagnosis , Keratoderma, Palmoplantar/diagnosis , Tinea Capitis/diagnosis , SyndromeABSTRACT
Dermatology has a very distinctive lexicon. The term pityriasis refers to several dermatologic conditions which all feature scaling of the skin. According to the Merriam-Webster dictionary, the term pityriasis was first used in print in 1684. Although the diseases beginning with the name pityriasis are of diverse causation, they do represent important dermatologic diseases, with some common and others quite rare. It is important for dermatologists to be aware and updated on all pityriasis conditions in dermatology.
Subject(s)
Dermatology , Pityriasis , Humans , Pityriasis/diagnosis , SkinABSTRACT
BACKGROUND: Pityriasis Alba (PA) is a common skin disorder affecting the children and it has multiple risk factors. OBJECTIVES: To assess the serum levels of trace elements (copper, zinc, and magnesium) and hemoglobin (Hb) level in patients with PA. METHOD: This is a case control study; 110 participants (55 cases and 55 controls) were recruited from pediatric dermatology and family medicine clinics, Cairo university hospitals. Patients were allocated into two groups, PA group (randomly selected male and female children age group (6-16) with PA lesions) and a matched control group. Full history was taken including sociodemographic data, present history of the lesions. Full general and dermatological examination was done. Blood samples were taken to asses iron and trace elements levels. The gained measures were analyzed by (SPSS) program version 22. RESULTS: This study showed that Hb levels, serum ferritin, copper, zinc and magnesium were significantly lower in PA group. There was statistically significant difference between both cases and controls regarding trace elements (copper, zinc, and magnesium) with (p value was 0.000, 0.000 and 0.003) respectively. Zinc deficiency increased the risk by more than 15 folds. Also, there was statistically significant difference between both groups regarding Hb levels and serum ferritin (p value was 0.000). The reduced Hb level increases the risk of PA by more than nine folds (OR 9.6) CONCLUSION: PA is associated with reduced levels of Hb, serum zinc, ferritin, copper and magnesium; sun exposure, skin phototype were found to be important risk factors for PA.
Subject(s)
Pityriasis/blood , Trace Elements/blood , Adolescent , Case-Control Studies , Child , Egypt , Female , Humans , Male , Pityriasis/diagnosis , Risk FactorsSubject(s)
Antineoplastic Agents/therapeutic use , Leukemia, Myeloid, Acute/complications , Pityriasis/diagnosis , Fetal Blood/transplantation , Filaggrin Proteins , Humans , Intermediate Filament Proteins/analysis , Leukemia, Myeloid, Acute/therapy , Male , Middle Aged , Pityriasis/etiology , Pityriasis/pathology , Pityriasis/therapy , Remission Induction/methods , Skin/pathology , Treatment OutcomeABSTRACT
Pityriasis folliculorum has been described as a dry type of rosacea with extensive proliferation of Demodex folliculorum in pilosebaceous follicles of the skin. This skin condition is frequently difficult to manage, with various treatment options showing mixed efficacy. Oral ivermectin, a macrocyclic lactone parasiticide with anti-inflammatory and anti-parasitic effects, is one of the leading treatment modalities for demodicosis. Topical ivermectin has recently been FDA approved as therapy for rosacea. We present the case of a woman with pityriasis folliculorum who showed significant improvement from using topical ivermectin with no adverse events related to treatment.
Subject(s)
Antiparasitic Agents/therapeutic use , Ivermectin/therapeutic use , Pityriasis/drug therapy , Administration, Cutaneous , Adult , Antiparasitic Agents/administration & dosage , Diagnosis, Differential , Female , Humans , Ivermectin/administration & dosage , Pityriasis/diagnosis , Pityriasis/pathologyABSTRACT
We report on a 21-year-old woman with a 3-year history of crusts and erosions on her scalp that had appeared after starting treatment with adalimumab due to Crohn's disease. By clinicopathological correlation pityriasis amiantacea with underlying folliculitis decalvans was diagnosed. Topical and systemic antibiotic treatment showed rapid response. The occurrence of pityriasis amiantacea in folliculitis decalvans associated with tumor necrosis factor (TNF)-α inhibitor therapy is remarkable and highlights the ambivalent role of TNF-α in diseases with immunological dysfunctions in combination with infections.
Subject(s)
Adalimumab/adverse effects , Alopecia/chemically induced , Crohn Disease/drug therapy , Folliculitis/chemically induced , Pityriasis/chemically induced , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab/therapeutic use , Alopecia/diagnosis , Diagnosis, Differential , Female , Folliculitis/diagnosis , Folliculitis/pathology , Humans , Injections, Subcutaneous , Pityriasis/diagnosis , Pityriasis/pathology , Scalp/drug effects , Scalp/pathology , Young AdultSubject(s)
Hypopigmentation/etiology , Humans , Inflammation/complications , Inflammation/diagnosis , Nevus, Halo/complications , Nevus, Halo/diagnosis , Patient Education as Topic , Pityriasis/complications , Pityriasis/diagnosis , Pityriasis/drug therapy , Vitiligo/complications , Vitiligo/diagnosis , Vitiligo/drug therapyABSTRACT
La psoriasis es una enfermedad cutánea crónica caracterizada más frecuentemente por placas eritematosas que aparecen normalmente con una distribución característica en superficie de extensión de extremidades, zonas de presión y cuero cabelludo. Aunque el diagnóstico diferencial de la psoriasis es amplio, el reconocimiento de esta entidad puede ser realizado mediante una correcta anamnesis y exploración física en la mayoría de los casos. La psoriasis folicular es una variante infradiagnosticada entre las diversas formas de psoriasis bien documentadas en la bibliografía (AU)
Psoriasis is a chronic skin disorder most commonly characterized by well-demarcated erythematous plaques with a typical distribution on extensor areas of limbs, pressure areas and scalp. Although the differential diagnosis of psoriasis is broad, its identification can be made by means of careful anamnesis and physical examination in the vast majority of cases. Follicular psoriasis is an under-diagnosed variant among the other well documented forms of psoriasis (AU)
Subject(s)
Humans , Male , Female , Child , Psoriasis/diagnosis , Psoriasis/drug therapy , Skin Diseases/diagnosis , Skin Diseases/drug therapy , Pityriasis/diagnosis , Pityriasis/drug therapy , Pityriasis/physiopathology , Pityriasis Rubra Pilaris/complications , Pityriasis Rubra Pilaris/drug therapy , Adrenal Cortex Hormones/therapeutic use , Cyclosporine/therapeutic use , Primary Health Care/methods , Betamethasone/therapeutic use , Fluticasone/therapeutic use , Keratoderma, Palmoplantar/drug therapy , Diagnosis, DifferentialABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Pityriasis/diagnosis , Hyperprolactinemia/complications , Ichthyosis/diagnosis , Diagnosis, DifferentialSubject(s)
Ketoconazole/administration & dosage , Pityriasis , Skin/pathology , Administration, Topical , Adult , Antifungal Agents/administration & dosage , Atrophy , Back , Biopsy/methods , Diagnosis, Differential , Female , Humans , Pityriasis/diagnosis , Pityriasis/drug therapy , Prognosis , Treatment OutcomeABSTRACT
Pityriasis amiantacea is a rare cutaneous reaction pattern to various underlying inflammatory diseases of the scalp. The clinical findings are very characteristic but often under-recognized. This condition can lead to scarring alopecia, and can be refractory to conservative treatment. It is therefore important to recognize the condition so that appropriate treatment can be initiated promptly.
